extemporaneous compoundingSyrSpend SF PH4University of AthensFagron Group
…with a practical, evidence-based framework for dose accuracy in extemporaneous compounding. Demonstrating reliable content uniformity and stability across…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 301–360 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Pharmacological management5Speech and Language Therapy5Steroid treatment5TB treatment5Transcatheter aortic valve replacement5antitubercular therapy5corrective surgery5disease-modifying therapies5drug therapy5fluid resuscitation5intravenous immunoglobulin5invasive ventilation5manual therapy5targeted treatments5vaccination5ECT4CBTi4IPT4Venesection4Palliative sedation4PLEX4TAVR4ACP4ICI rechallenge4OMT4BMT4DMT4Phage therapy4Adjuvant immunotherapy4PTAS4Radical cystectomy4SAVR4menopausal hormone therapy4Antifibrotic therapy4DMTs4Drug treatment4Microsurgical clipping4electrotherapy4Epilepsy surgery4Music therapy4thromboprophylaxis4CAS4Opioid therapy4RPT4paracentesis4Allo-HSCT4PD-1 blockade4Pharmacotherapies4pain management4stenting4surgical evacuation4hysterectomy4Beta-blocker therapy4EUS-GE4Non-pharmacological therapies4Stent placement4brachytherapy4therapeutics4Adjuvant radiotherapy4Cell therapy4
Articles mentioning treatments
7,227 articles · page 193 of 603preventive therapiesmigrainegalcanezumaberenumabeptinezumabatogepantfremanezumab
…n and Relevance In this real-world migraine cohort of patients, preventive therapies targeting the CGRP pathway led to sustained clinical improvemen…
anti-CGRP monoclonal antibodiesGepantsgepantrimegepantatogepantCMchronic migrainehigh-frequency episodic migraineHFEM
… in naive patients compared to patients previously treated with anti-CGRP monoclonal antibodies.Aim and Objectives To compare the effectiveness and safety of g…
ETAELAFIBRANORSELADELPAROBETICHOLIC ACIDprimary biliary cholangitisPBCPubMedEMAEuropean Medicines AgencyELF+1 more
…margin was 0.0%.Conclusion and Relevance In accordance with the ETA guideline, ELF can be considered ETA compared to OCA and SEL in…
biologicsbiologic therapyadalimumabmoderate-to-severe psoriasisEQ-5DPsoriasisdermatology
…trol in patients with moderate-to-severe psoriasis treated with biologics and to analyse discrepancies between PROs and the Psoriasis Are…
prophylactic treatmenthaemophiliaemicizumabefmoroctocog alfalonoctocog alfaturoctocog alfasimoctocog alfaalbutrepenonacog alfahaemophilia BHIV+1 more
… (16.3%), hepatitis C (9.3%) and HIV (2.3%). Of the patients on prophylactic treatment, 98.7% were adherent. Median overall score of the WHOQOL-BREF q…
corticosteroidsplasma exchangeRituximabCaplacizumabThrombotic thrombocytopenic purpuraTTP
…serious disease. Initial treatment includes plasma exchange and corticosteroids, with relapses occurring in 20–50% of cases. Rituximab and capl…
phage therapyMultidrug–resistant (MDR) infections
…and a lot release LIMS compliant dossiers);To support precision phage therapy against MDR pathogens.Material and Methods DeepPL was used for …
antiretroviral therapyARTPLWHIVHIV
…as conducted. We included older PLWHIV (≥65 years) who received antiretroviral therapy (ART) from hospital pharmacies of ten Spanish public hospitals …
anticancer treatmentoncological treatmentgarlicnon-small-cell lung cancerHPoreganochamomilepeppergingerthyme+4 more
…ver, unsupervised use may compromise the efficacy and safety of anticancer treatment due to potential drug–herb interactions.Aim and Objectives To e…
chemotherapydual HER2 blockadePertuzumabTrastuzumab
…h dual HER2 blockade, combining Trastuzumab and Pertuzumab with chemotherapy, is currently the therapeutic option in the neoadjuvant setting…
antimicrobial therapytertiary care hospitalBSIBloodstream infections
… high morbidity and mortality, requiring prompt and appropriate antimicrobial therapy. Antimicrobial Stewardship Programmes (ASPs) review positive bl…